Loading stock data…
AMS
$1.70+0.25 (+17.24%)
Market ClosedLast close May 1
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
American Shared Hospital Services in the Healthcare sector is trading at $1.70. The stock is currently 45% below its 52-week high of $3.11, remaining 21.3% below its 200-day moving average. Technical signals show neutral RSI of 69 and bullish MACD crossover, explaining why AMS maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 69) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.70
Potential Upside
5%
Whystock Fair Value$1.78
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments, Leasing and Retail. The company leases nine Gamma Knife systems and one ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.91M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.29
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-9.45%
Volume
Today's trading volume
1.06M
Recent News
Advanced Medical Solutions Group And 2 Other UK Stocks That May Be Trading Below Their Estimated Value
As the UK market grapples with global economic uncertainties, notably influenced by China's sluggish recovery and its impact on commodity-linked stocks, investors are keenly observing the performance of major indices like the FTSE 100 and FTSE 250. In such a volatile environment, identifying undervalued stocks can offer opportunities for those seeking potential value investments; Advanced Medical Solutions Group and two other UK companies may currently be trading below their estimated value.
American Shared Hospital Services Q4 2025 Earnings Call Summary
Moby summary of American Shared Hospital Services's Q4 2025 earnings call
American Shared Hospital Services (AMS) Q4 2025 Earnings Call Highlights: Navigating Revenue ...
Despite a challenging quarter with revenue declines, AMS focuses on expanding its direct patient care services and strengthening strategic partnerships for future growth.
Retail investors account for 59% of ams-OSRAM AG's (VTX:AMS) ownership, while institutions account for 41%
Key Insights ams-OSRAM's significant retail investors ownership suggests that the key decisions are influenced by...
A Look at ams-OSRAM (SWX:AMS) Valuation After Cautious Q4 Outlook and Analyst Downgrades
ams-OSRAM (SWX:AMS) saw its shares tumble after management issued fourth-quarter revenue and margin guidance that came in lower than the market expected. The company’s updated outlook quickly became the main focus for investors. See our latest analysis for ams-OSRAM. Even before this week’s cautious outlook, ams-OSRAM’s stock had been on a bumpy ride. After climbing earlier in the year, momentum faded sharply, with a 31.6% share price decline over the past month and a 22.6% drop just this...